Introducing ‘Families of Hope’ from Netcells By Next Biosciences 5 September 2016 We started discussing the form our corporate social investment would take well over a year ago.
Brain injury stem cell therapy advances By Dr Michelle Mason 20 July 2016 There enormous growth in perinatal stem cell research, particularly the non-haematological uses of both cord blood and cord tissue stem cells.
HLA matching embryos for the potential treatment of life-threatening conditions By Jaysen Knezovich 20 July 2016 Current academic views on cord blood banking are still conservative as the lifetime likelihood of developing a blood-related disease requiring transplantation remains low.
Innovative wound-healing technique using amniotic membrane By Next Biosciences 13 July 2016 According to a recent article in Live Science, human amniotic membrane biological patches can be used to treat superficial wounds such as partial thickness burn wounds, diabetic foot ulcers, venous leg ulcers and bed sores.
A second Netcells baby heads to the US for stem cell treatment By Next Biosciences 12 July 2016 Our Netcells team is proud to announce that we have released a second unit of umbilical cord blood belonging to a three-year-old Netcells baby born with cerebral palsy.
July is Cord Blood Awareness Month By Next Biosciences 7 July 2016 Expectant parents are faced with a number of decisions before the birth of a baby, among them whether to collect the baby’s umbilical cord blood at birth.
Next Biosciences and Genesis, Genetics South Africa combine their DNA By Next Biosciences 20 May 2016 The merger of local leaders in stem cell banking and genetic testing consolidates their position in the African biotechnology industry.
Next Biosciences offers FirstScreen By 20 April 2016 A newborn screening test is done in collaboration with North-West University and includes tests relevant to the South African population.
Next Biosciences’ donation to CHOC By Next Biosciences 16 April 2016 Next Biosciences will work closely with CHOC to ensure that any unutilised funds from procedural fees donated by obstetricians will be directed to CHOC, as the Netcells ‘Families of Hope’ programme’s goals are closely aligned to theirs: Keeping more than hope alive.
Next Biosciences’ Dr Nick Walker is off to Silicon Valley By Next Biosciences 11 April 2016 Winner of first South African Global Impact Competition presents an innovative concept to address HIV/AIDS.